Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life is a research paper published in Clinical Infectious Diseases (2020). On theSindex it has a DataRank of 1.0. It has been cited 28 times, with 15 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.505
From this paper's citation signal
Citation Network Contribution
0.508
From 12 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 15 citers.
National Institute of Allergy and Infectious Diseases
Grant: U01AI14235
NIAID NIH HHS
Grant: K24 AI131924
NIAID NIH HHS
Grant: P30 AI060354
NIAID NIH HHS
Grant: UM1 AI069536
NIAID NIH HHS
Grant: U01 AI114235
National Institutes of Health
Grant: 1P30AI060354-01
Harvard Medical School Center for AIDS Research
National Institutes of Health
FWCI
0.46
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals